A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
A mild night with winds strengthening. A windy day on Sunday with sunny spells and warmer air. Kerrie has the detail......
Ukip leader Paul Nuttall has announced that he will be standing for the seat of Boston and Skegness in the forthcoming General Election.
Here's the forecast for the next few days....